The Recall Desk
LowFDA (Drugs)·D-742-2014·Announced 2014-01-22

Novartis Recalls Theraflu Warming Relief Due to Unknown Degradant

Novartis Consumer Health is recalling Theraflu Warming Relief caplets because an unknown degradant was found during stability testing.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The source text explicitly states the agency classification is Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.

Plain-English summary

Novartis Consumer Health, Inc. is recalling Theraflu Warming Relief, Multi-Symptom Cold, Acetaminophen 325mg, Dextromethorphan HBr 10mg, Phenylephrine HCL 5mg. The recall involves 8-caplet and 24-caplet packages distributed nationwide and in Mexico, Panama, Ecuador, and Venezuela.

The recall was initiated because an unknown degradant was found during stability testing. The agency has classified this as a Class III recall, indicating that the product is unlikely to cause adverse health consequences.

Consumers should stop using the affected products and return them to the place of purchase for a refund or contact Novartis Consumer Health for further instructions.

The recalled product

Product
Theraflu Warming Relief, Multi-Symptom Cold, Acetaminophen 325mg, Dextromethorphan HBr 10mg, Phenylephrine HCL 5mg, packaged in a) 8 coated caplets (NDC 0067-6438-08) b) 24 coated caplets (NDC 0067-6438-24), Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-06

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 7 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 7 products in this recall →